Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Shockwave Javelin IVL catheter shows positive results in pivotal FORWARD CAD study


Impella registry analyses report lower mortality than CHIP-BCIS3 in high-risk PCI


FDA approves Abbott’s Amplatzer Paraclose device for heart valve leaks


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

An impurity detected in a stability study: Did we miss anything in our E&L risk assessment?

Presented by Petra Booij, Investigator bij GlaxoSmithKline and Ward D’Autry, PhD Study Director at Nelson Labs Europe
15th March 2022


Establishing Early Development Strategies For Therapeutics Proteins

Presented by Sorina Morar-Mitrica, Principal Fellow Sr Drug Product Lead Early Phase Biologics at Novartis and Bernardo Cordovez, PhD, Chief Science Officer & Founder, Halo Labs
21st October 2020


Alignment to Standardized Extractables Testing, Facilitating Single-Use Adoption

Presented by Presenter: James Hathcock, Ph.D., Moderator: Hélène Pora, Ph.D.
29th June 2017


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia